Published in Ann Otol Rhinol Laryngol on December 29, 1979
Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss | NCT02828033
Increased levels of mean platelet volume: a possible relationship with idiopathic sudden hearing loss. Eur Arch Otorhinolaryngol (2013) 2.79
Chronic cerebrospinal venous insufficiency in patients with Ménière's disease. Eur Arch Otorhinolaryngol (2013) 1.43
Retracted Exogenous IL-4-expressing bone marrow mesenchymal stem cells for the treatment of autoimmune sensorineural hearing loss in a guinea pig model. Biomed Res Int (2014) 1.40
Retracted Experimental study of local inner ear gene therapy for controlling autoimmune sensorineural hearing loss. Biomed Res Int (2014) 1.38
A study on peripheral vertigo in a Kolkata based hospital. Indian J Otolaryngol Head Neck Surg (2002) 1.08
Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation. J Assoc Res Otolaryngol (2003) 1.07
Corticosteroid therapy for hearing and balance disorders. Anat Rec (Hoboken) (2012) 1.02
Alternate splicing of interleukin-1 receptor type II (IL1R2) in vitro correlates with clinical glucocorticoid responsiveness in patients with AIED. PLoS One (2009) 1.02
IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease. J Immunol (2011) 1.01
Autoantibodies to recombinant human CTL2 in autoimmune hearing loss. Laryngoscope (2009) 1.01
Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med (2011) 0.99
The therapeutic efficacy of human adipose tissue-derived mesenchymal stem cells on experimental autoimmune hearing loss in mice. Immunology (2011) 0.96
Allelic variants in TLR10 gene may influence bilateral affectation and clinical course of Meniere's disease. Immunogenetics (2013) 0.94
High prevalence of systemic autoimmune diseases in patients with Menière's disease. PLoS One (2011) 0.93
Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease: A physiopathologic approach. Eur Arch Otorhinolaryngol (2006) 0.91
Abnormal basement membrane in the inner ear and the kidney of the Mpv17-/- mouse strain: ultrastructural and immunohistochemical investigations. Histochem Cell Biol (2005) 0.90
Sensorineural deafness--a new complication of ulcerative colitis? Postgrad Med J (1986) 0.88
Antibody reactivity to heat shock protein 70 and inner ear-specific proteins in patients with idiopathic sensorineural hearing loss. Clin Exp Immunol (2006) 0.86
Vertigo and autoimmunity. Eur Arch Otorhinolaryngol (2009) 0.85
Clinical Subgroups in Bilateral Meniere Disease. Front Neurol (2016) 0.85
Polymorphisms of CD16A and CD32 Fcγ receptors and circulating immune complexes in Ménière's disease: a case-control study. BMC Med Genet (2011) 0.83
Antibodies to inner ear antigens in Meniere's disease. Clin Exp Immunol (2004) 0.83
Possible association between thyroid autoimmunity and Menière's disease. Clin Exp Immunol (2008) 0.83
Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss. Front Pharmacol (2014) 0.82
Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol (2006) 0.82
The role of glucocorticoids for spiral ganglion neuron survival. Brain Res (2009) 0.82
Acute sensorineural hearing loss as an early manifestation of indeterminate colitis. Dig Dis Sci (2004) 0.82
Immunosuppressive therapy for autoimmune inner ear disease. Immunotherapy (2009) 0.82
TNFalpha blockers do not improve the hearing recovery obtained with glucocorticoid therapy in an autoimmune experimental labyrinthitis. Eur Arch Otorhinolaryngol (2006) 0.82
Prognostic factors in sudden hearing loss. J Med Life (2010) 0.81
The occurrence of sensorineural hearing loss in a patient with myeloperoxidase-anti-neutrophil cytoplasmic antibody-related microscopic polyangiitis. Rheumatol Int (2007) 0.81
Immunohistochemical findings in the vestibular ganglion from a patient with Menière's disease. Eur Arch Otorhinolaryngol (1990) 0.80
Innate immune recognition of molds and homology to the inner ear protein, cochlin, in patients with autoimmune inner ear disease. J Clin Immunol (2013) 0.80
Does rheumatoid arthritis have an effect on audiovestibular tests? Eur Arch Otorhinolaryngol (2013) 0.79
Acute Hearing Loss. Curr Treat Options Neurol (2004) 0.79
Detection of asymptomatic cranial neuropathies in patients with systemic lupus erythematosus and their relation to antiribosomal P antibody levels and disease activity. Clin Rheumatol (2014) 0.78
Constraint-induced sound therapy for sudden sensorineural hearing loss--behavioral and neurophysiological outcomes. Sci Rep (2014) 0.78
Old mice lacking high-affinity nicotine receptors resist acoustic trauma. Hear Res (2011) 0.78
AAO: Autoimmune and Autoinflammatory (Disease) in Otology: What is New in Immune-Mediated Hearing Loss. Laryngoscope Investig Otolaryngol (2016) 0.78
Biological and clinical aspects of autoimmune inner ear disease. Yale J Biol Med (1992) 0.78
Short-Term Outcomes of Acute Low-Tone Sensorineural Hearing Loss According to Treatment Modality. J Audiol Otol (2016) 0.77
Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis. Ther Clin Risk Manag (2010) 0.77
The role of allergy in the etiopathogenesis of idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol (2012) 0.77
Serum antibodies against membranous labyrinth in patients with "idiopathic" bilateral vestibulopathy. J Neurol (1998) 0.76
Evaluation of Hearing and Outer Hair Cell Function of Cochlea in Patients With Psoriatic Arthritis. Clin Exp Otorhinolaryngol (2015) 0.76
IL-1β inhibition in autoimmune inner ear disease: can you hear me now? J Clin Invest (2014) 0.75
Examination of Hearing in a Rheumatoid Arthritis Population: Role of Extended-High-Frequency Audiometry in the Diagnosis of Subclinical Involvement. Scientifica (Cairo) (2016) 0.75
IgG4-Related Disease and Sensorineural Hearing Loss. Clin Exp Otorhinolaryngol (2014) 0.75
Focal Endolymphatic Hydrops as Seen in the Pars Inferior of the Human Inner Ear. Otol Neurotol (2016) 0.75
New prospects in the diagnosis and treatment of immune-mediated inner ear disease. World J Methodol (2014) 0.75
Reiter's syndrome and hearing loss: a possible association? Clin Case Rep (2014) 0.75
Immune complex-associated deafness: preliminary communication. J R Soc Med (1985) 0.75
HLA-Cw Allele Frequency in Definite Meniere's Disease Compared to Probable Meniere's Disease and Healthy Controls in an Iranian Sample. Iran J Otorhinolaryngol (2016) 0.75
Temporal bone histopathology and immunoglobulin deposition in Sjogren's syndrome. Otol Neurotol (2012) 0.75
Neuro-otological syndromes for the neurologist. J Neurol Neurosurg Psychiatry (2004) 0.75
Anti-laminin antibodies in inner ear diseases: a potential marker for infectious and post-infectious processes. Arch Otorhinolaryngol (1989) 0.75
N-Acetylcysteine attenuates tumor necrosis factor alpha levels in autoimmune inner ear disease patients. Immunol Res (2015) 0.75
Therapy of hearing disorders - conservative procedures. GMS Curr Top Otorhinolaryngol Head Neck Surg (2005) 0.75
Commentary. J Neurosci Rural Pract (2015) 0.75
Mobile tablet audiometry in fluctuating autoimmune ear disease. J Otolaryngol Head Neck Surg (2017) 0.75
Intratympanic dexamethasone application in Meniere's disease-Is it superior to conventional therapy? Indian J Otolaryngol Head Neck Surg (2005) 0.75
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss. J Vis Exp (2016) 0.75
Cochlear Impairment and Autoimmune Ear Disorder in a Patient with Breast Cancer. Audiol Res (2017) 0.75
Incidence of Hypothyroidism in Meniere's Disease. J Clin Diagn Res (2016) 0.75
Bio-recognition and functional lipidomics by glycosphingolipid transfer technology. Proc Jpn Acad Ser B Phys Biol Sci (2013) 0.75
Serum immunoglobulins in 28 adults with autoimmune sensorineural hearing loss: increased prevalence of subnormal immunoglobulin G1 and immunoglobulin G3. BMC Immunol (2014) 0.75
Recurrent autoimmune inner ear disease (AIED) and polyarteritis nodosa in a patient with large cell lung carcinoma. Clin Rheumatol (2006) 0.75
Impaired CD4+CD25+ regulatory T cell activity in the peripheral blood of patients with autoimmune sensorineural hearing loss. Eur Arch Otorhinolaryngol (2008) 0.75
Hearing loss in vitiligo: current concepts and review. Eur Arch Otorhinolaryngol (2017) 0.75
[Manifestations of autoimmune disorders in otorhinolaryngology : Classical symptoms and diagnostic approach]. HNO (2017) 0.75
Sudden Sensorioneural Hearing Loss and Autoimmune Systemic Diseases. Int Arch Otorhinolaryngol (2016) 0.75
Effects of testosterone in the treatment of immune-mediated sensorineural hearing loss. Eur Arch Otorhinolaryngol (2003) 0.75
Significance of node biopsy before definitive treatment of cervical metastatic carcinoma. Laryngoscope (1978) 2.45
Perilymph fistula: the Iowa experience. Laryngoscope (1986) 1.22
Evaluation of five different cochlear implant designs: audiologic assessment and predictors of performance. Laryngoscope (1988) 1.19
Use of multichannel cochlear implants in obstructed and obliterated cochleas. Otolaryngol Head Neck Surg (1988) 1.08
Does perilymph modify cupula deflection? Acta Otolaryngol (1973) 0.98
Hearing results after cholesteatoma surgery: the Iowa experience. Laryngoscope (1987) 0.97
Syndrome of inappropriate secretion of arginine vasopressin in patients with cancer of the head and neck. Ann Otol Rhinol Laryngol (1992) 0.95
Further experiments on vestibular compensation. Laryngoscope (1972) 0.93
Experiments on vestibular compensation. Laryngoscope (1969) 0.92
The prognostic significance of metastatic cervical lymph nodes. Laryngoscope (1980) 0.91
The osteo-mucoperiosteal flap in repair of cerebrospinal fluid rhinorrhea. Laryngoscope (1976) 0.90
Interferon and laryngeal papillomatosis. The Iowa experience. Ann Otol Rhinol Laryngol (1983) 0.89
Regeneration of the recurrent laryngeal nerve. Otolaryngol Head Neck Surg (1983) 0.89
The osteo-mucoperiosteal flap in repair of cerebrospinal fluid rhinorrhea: a 20-year experience. Otolaryngol Head Neck Surg (1989) 0.88
Facial nerve grafting. Plast Reconstr Surg (1970) 0.87
Lightning injury of the tympanic membrane. Ann Otol Rhinol Laryngol (1993) 0.87
Carcinoma of the oral cavity. Arch Otolaryngol (1973) 0.87
Middle cranial fossa acoustic neuroma excision: results and complications. Ann Otol Rhinol Laryngol (1986) 0.87
The effect of accurate neurorrhaphy on reinnervation and return of laryngeal function. Laryngoscope (1968) 0.86
Ototoxicity of oral neomycin and vancomycin. Laryngoscope (1983) 0.86
Tinnitus and acoustic neuromas: analysis of the effect of surgical excision on postoperative tinnitus. Ear Nose Throat J (1995) 0.86
Some observations on the cryobiology of blood vessels. Laryngoscope (1967) 0.86
Meniere's disease at the University of Iowa: 1973 to 1980. Otolaryngol Head Neck Surg (1983) 0.85
Atticotomy: a neglected otosurgical technique. Ann Otol Rhinol Laryngol (1974) 0.85
The risks of major head and neck surgery in the aged population. Laryngoscope (1977) 0.84
Drug effects on the medial vestibular nucleus. Arch Otolaryngol (1971) 0.84
Iowa results of acoustic neuroma operations. Laryngoscope (1978) 0.84
Drug effects on postlabyrinthectomy nystagmus. Arch Otolaryngol (1973) 0.83
Congenital middle ear aneurysm of internal carotid. Arch Otolaryngol (1969) 0.83
Results of conservative surgery for middle ear cholesteatoma. Laryngoscope (1977) 0.83
Effects of attention-requiring tasks on vestibular nystagmus. Ann Otol Rhinol Laryngol (1980) 0.83
Mondini dysplasia and congenital cytomegalovirus infection. J Pediatr (1994) 0.83
Preservation of cochlear function after extensive labyrinthine destruction. Ann Otol Rhinol Laryngol (1977) 0.82
Labyrinthine exercises in the treatment of diseases characterized by vertigo: their physiologic basis and methodology. Laryngoscope (1970) 0.82
Lipoid proteinosis of the larynx: a cause of voice change in the infant and young child. Int J Pediatr Otorhinolaryngol (1988) 0.82
Initial Iowa results with the multichannel cochlear implant from Melbourne. J Speech Hear Res (1984) 0.82
Clinicopathological consultation. Ear cholesteatoma versus cholesterol granuloma. Ann Otol Rhinol Laryngol (1997) 0.82
Tests for autoimmune disease in otology. Am J Otol (1984) 0.82
Vascular loop as a cause of vertigo. Ann Otol Rhinol Laryngol (1984) 0.81
Disappearing recurrent acoustic neuroma in an elderly woman. Ann Otol Rhinol Laryngol (1993) 0.81
Central vestibular compensation. Effect of the bilateral labyrinthectomy on neural activity in the medial vestibular nucleus. Arch Otolaryngol (1976) 0.81
Salivary gland neoplasms in children. Otolaryngol Clin North Am (1977) 0.81
Temporal bone fractures and facial nerve injury. Otolaryngol Clin North Am (1974) 0.81
Effect of radiation therapy on facial nerve cable autografts. Laryngoscope (1977) 0.81
Labyrinithine fistula complicating chronic suppurative otitis media. Arch Otolaryngol (1974) 0.81
Increased survival with surgery alone vs. combined therapy. Laryngoscope (1979) 0.81
Selection of therapy of glomus jugulare tumors. Arch Otolaryngol (1969) 0.80
Neurilemmoma of the ninth cranial nerve masquerading as an acoustic neuroma. Arch Otolaryngol (1974) 0.80
Diatrizoate and dextran treatment of sudden sensorineural hearing loss. Am J Otol (1995) 0.80
Anti-Epstein Barr virus antibody in nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol (1974) 0.80
Phonosurgery: indications and pitfalls. Ann Otol Rhinol Laryngol (1989) 0.80
Perilymph fistula: an important cause of deafness and dizziness in children. Pediatrics (1987) 0.80
Combined radiation and surgical therapy: tongue, tonsil and floor of mouth. Ann Otol Rhinol Laryngol (1968) 0.80
Tube-perilymph fistula. An experimental study. Chin Med J (Engl) (1992) 0.80
Types of neuronal activity in the medial vestibular nucleus. Acta Otolaryngol (1970) 0.79
The effect of diazepam on vestibular compensation. Laryngoscope (1974) 0.79
Homograft tympanoplasty: the Iowa experience. Am J Otol (1990) 0.79
Symposium on acoustic neuroma. 3. Neural vs. sensory lesion: vestibular signs. Laryngoscope (1966) 0.79
Drug effects on the medial vestibular nucleus. Perrotatory response. Arch Otolaryngol (1971) 0.79
Labyrinthine fistula in chronic mastoiditis. Ann Otol Rhinol Laryngol Suppl (1984) 0.78
Facial nerve function following irradiated cable grafts. Laryngoscope (1989) 0.78
Bilateral radical neck dissections. Arch Otolaryngol (1980) 0.78
Factors influencing tympanostomy tube function and extrusion: a study of 1,127 ears. Otolaryngol Head Neck Surg (1985) 0.78
Teflon injection in the nasopharynx to improve velopharyngeal closure. Ann Otol Rhinol Laryngol (1977) 0.77
Further experiments on vestibular compensation. Adv Otorhinolaryngol (1973) 0.77
Early diagnosis of otologic Wegener's granulomatosis using the serologic marker C-ANCA. Ann Otol Rhinol Laryngol (1993) 0.77
Injuries to the facial nerve. Laryngoscope (1972) 0.77
Neuronal habituation in the vestibular nuclei of the cat. Acta Otolaryngol (1981) 0.77
Central aspects of drugs for motion sickness and vertigo. Adv Otorhinolaryngol (1973) 0.76
Management of hyperfunction of the facial nerve. Ann Otol Rhinol Laryngol (1970) 0.76
Controllable variables in vestibulometry. Arch Otolaryngol (1967) 0.76
Gustatory otorrhea: Frey's syndrome of the external auditory canal. Ann Otol Rhinol Laryngol (1993) 0.76
Temporal lobe tumor manifested by localized dysgeusia. Ann Otol Rhinol Laryngol (1990) 0.76
The effect of hyperbaric oxygen on growth of human squamous cell carcinoma xenografts. Arch Otolaryngol Head Neck Surg (1991) 0.76
Audiological results with two single channel cochlear implants. Ann Otol Rhinol Laryngol (1985) 0.76
Voice button prosthesis rehabilitation of the laryngectomee. Additional notes. Ann Otol Rhinol Laryngol (1982) 0.76
Audiologic results following reimplantation of cochlear implants. Ann Otol Rhinol Laryngol Suppl (1989) 0.76
Some evidence for the efficacy of decompression for Bell's palsy: immediate motion postoperatively. Laryngoscope (1977) 0.75
Nonlinear characteristics of single neurons in the vestibular nuclei. Ann N Y Acad Sci (1981) 0.75
Dean M. Lierle, MD. Ann Otol Rhinol Laryngol (1977) 0.75
Epidermoid carcinoma of the floor of the mouth: surgical therapy vs combined therapy vs radiation therapy. Otolaryngol Head Neck Surg (1979) (1981) 0.75
Second-order vestibular adaptation and cupular dynamics. Ann Otol Rhinol Laryngol (1980) 0.75
Barry J. Anson 1894 - 1974. Ann Otol Rhinol Laryngol (1975) 0.75
An alternative approach to the pterygopalatine fossa by removing the mandible and immediately replacing it. Otolaryngology (1979) 0.75
Research vistas in chronic otitis media. Clin Otolaryngol Allied Sci (1978) 0.75
Characterization of tumor antigen in epidermoid carcinoma. Ann Otol Rhinol Laryngol (1976) 0.75
Trigeminal neurilemmoma presenting as a sphenoid sinus mass. Surg Neurol (1979) 0.75
Indium 111-labeled white blood cell scintigraphy as an unreliable indicator of malignant external otitis resolution. Ann Otol Rhinol Laryngol (1994) 0.75
The giant apical air cell syndrome. A new entity. Ann Otol Rhinol Laryngol (1982) 0.75
Responses to step and repeated impulse accelerations in second order vestibular neurons of the cat. Am J Otolaryngol (1980) 0.75
Resident research in otolaryngology at the University of Iowa. Can J Otolaryngol (1975) 0.75
Malignant fibrous histiocytoma of the nose and nasopharynx. Arch Otolaryngol (1981) 0.75
Photoplethysmography in the prediction of experimental flap survival. Ann Otol Rhinol Laryngol (1979) 0.75
Otolaryngology and medicine today in the People's Republic of China. Ann Otol Rhinol Laryngol (1981) 0.75
Caldwell Luc self-retaining retractor. Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol (1975) 0.75
Management of facial paralysis due to temporal bone fracture. West J Med (1978) 0.75
The role of photoplethysmography in the prediction of the experimental flap survival. Otolaryngology (1979) 0.75
Paranasal sinus infection. Ann Otol Rhinol Laryngol (1986) 0.75
The problem of the collapsing upper lateral cartilage. Ann Otol Rhinol Laryngol (1979) 0.75